Dr. Harin Haridas Kanani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Haridas Kanani Family Trust, a promoter entity of Neogen Chemicals Limited, has submitted a declaration under SEBI Regulation 31(4) confirming encumbrance activity on the company's shares for the financial year ended March 31, 2026. The disclosure states that there was no creation, invocation, or release of encumbrances during the year, except for one event: Dr. Harin Kanani created a pledge on 13,19,083 equity shares of Neogen Chemicals Limited on March 30, 2026. This filing is a routine regulatory compliance requirement for promoter entities to disclose changes in share pledges.
The pledge of approximately 13.19 lakh shares by the promoter signals increased borrowing against company shares. Existing shareholders should monitor this as significant pledges by promoters can indicate financial stress or potential dilution risk if shares are invoked by lenders.